Brown Advisory’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-752,575	Closed	-$7.71M	–	1374
2018 Q4	$7.71M	Sell	752,575 -375,728	-33%	-$4.81M	0.03%	361
2018 Q3	$18.8M	Buy	1,128,303 +49,707	+5%	+$898K	0.05%	259
2018 Q2	$17M	Buy	1,078,596 +12,432	+1%	+$189K	0.05%	260
2018 Q1	$13.5M	Buy	1,066,164 +203,579	+24%	+$2.94M	0.04%	271
2017 Q4	$9.88M	Buy	862,585 +289,120	+50%	+$3.23M	0.03%	316
2017 Q3	$7.03M	Buy	573,465 +35,630	+7%	+$372K	0.02%	346
2017 Q2	$6.16M	Buy	537,835 +12,707	+2%	+$235K	0.02%	377
2017 Q1	$10.9M	Buy	525,128 +27,175	+5%	+$602K	0.04%	280
2016 Q4	$10.4M	Buy	497,953 +38,041	+8%	+$989K	0.04%	283
2016 Q3	$15.1M	Buy	459,912 +33,422	+8%	+$1.02M	0.05%	239
2016 Q2	$10.7M	Buy	426,490 +45,816	+12%	+$1.24M	0.04%	273
2016 Q1	$9.32M	Buy	380,674 +1,095	+0.3%	+$25.4K	0.03%	281
2015 Q4	$12.5M	Buy	379,579 +206,108	+119%	+$6.97M	0.04%	250
2015 Q3	$5.68M	Buy	173,471 +101,135	+140%	+$4.3M	0.02%	342
2015 Q2	$3.83M	Buy	+72,336	New	+$2.63M	0.01%	373